CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice.
Vincent WooAlan BellMaureen ClementLuis NoronhaMichael A TsoukasFernando CamachoShana TrainaNatasha GeorgijevMatthew D CulhamJennifer B RoseWally RapattoniHarpreet S BajajPublished in: Diabetes, obesity & metabolism (2018)
CANA provided sustained clinically meaningful improvements in cardiometabolic parameters in this study in a real-world setting, confirming findings from randomized controlled trials.